Sign in
Taking people in United StatesEarly phase 1

Thiamine Vitamin B1 Capsules Tested in Adults With Type 2 Diabetes

Tests whether vitamin B1 capsules improve brain function in adults with type 2 diabetes.

Key facts

Who runs it
University of California, Los Angeles
Where
Los Angeles, United StatesSee the site
Trial code
Registry title
Type 2 Diabetes and Blood Brain Barrier Improvement
Status
Recruiting
Phase
Early phase 1
People taking part
52 people, planned
Started
1 Aug 2024
Expected to end
31 Mar 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Thiamine
  • Placebo
Record updated
13 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 40 to 65 with type 2 diabetes who are outpatients and can lie flat for a brain MRI scan.

Age
40 Years to 65 Years
Sex
All sexes can join.
Disease stage
Diagnosed type 2 diabetes (T2DM), treated as an outpatient.
Earlier treatment
People who currently take thiamine cannot join.

Main reasons for not taking part

  • Previous stroke, head trauma, seizure disorder, or heart attack
  • Current pregnancy
  • Diagnosed dementia or neuropsychiatric disorders such as clinical depression or schizophrenia
  • Metal or electronic implants, pacemakers, or an insulin pump that cannot be removed
  • Body weight more than 300 pounds (136 kg), or other reasons that make an MRI unsafe such as claustrophobia

The registry criteria, word for word

Show all 24 criteriaShow less

Who can take part

  • Diagnosed T2DM
  • Outpatient status
  • Able to lay flat for imaging

Who cannot take part

  • A previous history of stroke
  • Known thiamine allergy
  • Seizure disorder
  • Myocardial infarction
  • Diagnosed neuropsychiatric disorders (clinical depression, schizophrenia, manic-depression)
  • Diagnosed dementia
  • Chronic obstructive pulmonary disease
  • Any history of drug abuse (e.g., cocaine, tobacco, or cannabis)
  • Renal failure (requiring dialysis)
  • All T2DM adults with metallic and electronic implants (phrenic or cardiac pacemakers; although some pacemakers and cardioverter defibrillators are safe at a low magnetic field, they are not safe at 3.0-Tesla scanner)
  • Non-removable insulin pump/glucose sensor
  • Current in-take of thiamine
  • Head trauma
  • Current pregnancy (if female)
  • Sleep disordered breathing
  • Airway or chest deformities that would interfere with breathing
  • Cystic fibrosis
  • Presence of brain mass lesions
  • Braces
  • Body weight more than 300 pounds (weight and height will be used to calculate BMI to determine if the patient will fit in the scanner and stay within parameters of size restrictions of MRI scanner table)
  • Any other contraindications to MRI, such as claustrophobia, or metallic-based tattoos, as per MRI safety website suggestions, will also be excluded

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 65 years old?

Where in United States

  • UCLALos Angeles, United StatesContact: Rajesh Kumar, PHDTaking people

About the trial

What the trial wants to find out

The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.

The 2 groups in the trial

  • BBB function, cognition, and mood in T2DM adults with Thiamine treatment.Treatment being tested

    Analyze BBB function, cognition, and mood in T2DM adults with Thiamine treatment and compare to the placebo group.

    Treatment: Thiamine

  • BBB function, cognition, and mood in T2DM adults without Thiamine treatment.Placebo, for comparison

    Analyze BBB function, cognition, and mood in T2DM adults without Thiamine treatment and compare to the Thiamine treatment group.

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Type 2 Diabetes Mellitus and Blood Brain Barrier Improvement - A Randomized Clinical Trial
Plain-language title
Thiamine Vitamin B1 Capsules Tested in Adults With Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06322212, who can take part
Record updated
13 March 2026